Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
Open Access
- 19 November 2021
- journal article
- research article
- Published by Springer Nature in npj Breast Cancer
- Vol. 7 (1) , 1-11
Abstract
Emerging data indicate that genomic alterations can shape immune cell composition in early breast cancer. However, there is a need for complementary imaging and sequencing methods for the quantitative assessment of combined somatic copy number alteration (SCNA) and immune profiling in pathological samples. Here, we tested the feasibility of three approaches—CUTseq, for high-throughput low-input SCNA profiling, multiplexed fluorescent immunohistochemistry (mfIHC) and digital-image analysis (DIA) for quantitative immuno-profiling- in archival formalin-fixed paraffin-embedded (FFPE) tissue samples from patients enrolled in the randomized SBG-2004-1 phase II trial. CUTseq was able to reproducibly identify amplification and deletion events with a resolution of 100 kb using only 6 ng of DNA extracted from FFPE tissue and pooling together 77 samples into the same sequencing library. In the same samples, mfIHC revealed that CD4 + T-cells and CD68 + macrophages were the most abundant immune cells and they mostly expressed PD-L1 and PD-1. Combined analysis showed that the SCNA burden was inversely associated with lymphocytic infiltration. Our results set the basis for further applications of CUTseq, mfIHC and DIA to larger cohorts of early breast cancer patients.Keywords
Funding Information
- Cancerfonden (CAN 2018/846, CAN 2017/1043, CAN 2018/728)
- Percy Falks Stiftelse för Forskning Beträffande Prostata- och Bröstcancer
- Knut och Alice Wallenbergs Stiftelse
- Radiumhemmets Forskningsfonder
- Vetenskapsrådet
- Stiftelsen för Strategisk Forskning (BD15_0095)
This publication has 65 references indexed in Scilit:
- Accuracy of Molecular Data Generated with FFPE Biospecimens: Lessons from the LiteratureCancer Research, 2015
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Signatures of mutational processes in human cancerNature, 2013
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancersGenome Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancerActa Oncologica, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- MYC and Breast CancerGenes & Cancer, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000